Celyad Reports First Half 2015 Financial Results and Operational Progress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
UBS Cuts Price Target on Celyad SA (CYAD) to $79 Following 1H15
August 26, 2015 8:50 AM EDTUBS maintained a Buy rating on Celyad SA (NASDAQ: CYAD), and cut the price target to $79.00 (from $82.00), following the company's 1H15 The key focus for analyst Andrew Peters is on timelines and the path forward for both the CHART program in heart failure as well as the NKG2D-based CAR-T therapy currently in phase-1 trials. Management confirmed that CHART-1 continues on-track, with top-line data... More
